☰

Ming-Fong Lin

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Molecular Biology, Biochemistry, Oncology
Google:
"Ming-Fong Lin"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Ming-Shyue Lee grad student 2002 University of Nebraska Medical Center
Siu-Ju Chen grad student 2006 University of Nebraska Medical Center
Ta-Chun Yuan grad student 2007 University of Nebraska Medical Center

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bhat AM, Mohapatra BC, Luan H, et al. (2023) Role of GD2 and its biosynthetic enzyme GD3 synthase in prostate cancer tumorigenesis. Biorxiv : the Preprint Server For Biology
Miller DR, Ingersoll MA, Chou YW, et al. (2022) Dynamics of antioxidant heme Oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression. Free Radical Biology & Medicine
Alpert E, Akhavan A, Gruzman A, et al. (2021) Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis. Bioscience Reports. 41
Alpert E, Akhavan A, Gruzman A, et al. (2021) Multifunctionality of Prostatic Acid Phosphatase in Prostate  Cancer Pathogenesis. Bioscience Reports
Miller DR, Ingersoll MA, Teply BA, et al. (2021) Targeting treatment options for castration-resistant prostate cancer. American Journal of Clinical and Experimental Urology. 9: 101-120
Abdul-Rida NA, Farhan AM, Al-Masoudi NA, et al. (2020) A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking study. Molecular Diversity
Miller DR, Ingersoll MA, Lin MF. (2019) ErbB-2 signaling in advanced prostate cancer progression and potential therapy Endocrine-Related Cancer. 26: R195-R209
Miller DR, Ingersoll MA, Chatterjee A, et al. (2019) p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance. Free Radical Biology & Medicine
Miller D, Ingersoll M, Chatterjee A, et al. (2019) Abstract 4285: p66Shc/ROS enhances the progression of androgen-sensitive towards castration-resistant prostate cancer cells Cancer Research. 79: 4285-4285
Miller DR, Tzeng CC, Farmer T, et al. (2018) Novel CIL-102 Derivatives as Potential Therapeutic Agents for Docetaxel-Resistant Prostate Cancer. Cancer Letters
See more...